Thoracic Cancer Beyond the Clinic - Community Impacts

Covid-19 rapidly affected our lives and the life of our patients. Vaccination campaign started in 2021. At least four types of vaccines are widely used in the US (Pfizer, Moderna, Johnson and Johnson and Astra Zeneca). Speakers review the data in the general population and available data in the cancer population. In general, the activity of the vaccines are similar for patients with solid tumors and the normal population. Possible influencing factor are chemotherapy, use of steroids and age. Data on larger cohort of patients with lung cancer are lacking.

Topics of discussions are:

  • Social Media Use in Medicine
  • Equity in Medicine
  • Wildfires and Climate Change: Effects on Lung Cancer
  • Efficacy of COVID Vaccine on Cancer Patients

An additional presentation on topics related with advanced precision diagnostics in the context of patients with thoracic malignancies is included. The presentation offers an update of optimal strategies to assess molecular biomarkers in tumor tissue samples and their impact in patient care.

This activity is available from January 31, 2022, through 11:59 p.m. Eastern time on January 30, 2025.

This activity was originally presented and recorded at 2021 Multidisciplinary Thoracic Cancers Symposium.

Target Audience

The activity is designed to meet the interests of radiation oncologists, radiation oncology residents, surgeons, physicists, nurses, radiation dosimetrists, radiation therapists, diagnostic radiologists, pathologists, medical oncologists and other specialists.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Apply new strategies to make practice modifications.
  • Describe the current landscape of biomarkers for targeted therapies and immunotherapy for patients with thoracic malignancies.

 

Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.50 Certificate of Attendance
    This activity was designated for 1.50 AMA PRA Category 1 Credit™.
Course opens: 
01/31/2022
Course expires: 
01/30/2025
Cost:
$30.00
Rating: 
0

Moderator: Marina Garassino, MD, University of Chicago, Chicago

Speakers:

  • ​​Katie Lichter, MD, University of California, San Francisco, California and has nothing to disclose.
  • Marina Garassino, MD, University of Chicago, Chicago and receives compensation from AstraZeneca, AstraZeneca/MedImmune, Bayer, Blueprint Medicines, Celgene, Daiichi Sankyo, Exelixis, GlaxoSmithKline, Incyte, Ipsen Bioscience Inc., Janssen, Medscape, Merck, Mirati Therapeutics Inc, MSD Oncology, Novartis, Otsuka Pharmaceutical Italy, Regeneron, Roche, S.O.S. S.r.l, Sanofi, Seattle Genetics, Spectrum Pharmaceuticals, Takeda, and Turning Point Therapeutics.
  • Howard (Jack) West, MD, City of Hope, Duarte, California and receives compensation from Amgen, Astrazeneca, Eli Lilly, Genentech/Roche, Merck and Mirati.
  • Narjust Duma, MD, Dana-Farber Cancer Institute, Boston and receives compensation from AstraZeneca, BI, BMS, Janssen, Neogenomics and Pfizer.

The person(s) above served as the developer(s) of this activity. Additionally, the ASTRO Education Committee had control over the content of this activity. All relevant financial relationships have been mitigated.

Disclosure link: 
ASTRO Education Committee

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.50 Certificate of Attendance
    This activity was designated for 1.50 AMA PRA Category 1 Credit™.

Price

Cost:
$30.00
Please login or register to take this course.

Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.

  • Nonmember: $30
  • Member: $25

If you are an ASTRO member from a low or lower-middle income country, as identified by the World Bank, you can receive a 50% discount off your corresponding registration for this activity. Please email [email protected] to inquire about the discount.

Policies:
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the activity by the expiration date.

Participants using ASTRO Academy activities to satisfy the requirement of a Continuing Certification (MOC) program should verify the credit number and type and availability dates of any activity before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased activities that do not align with their MOC requirement.

The activity and its materials will only be available on the ASTRO website until January 30, 2025, regardless of purchase date. At the expiration of the activity, participants will no longer have access to the activity or its materials. ASTRO reserves the right to remove an activity before its expiration date.

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.